Medicine & Life Sciences
Measles
100%
Rubella
69%
Zambia
47%
Vaccination Coverage
43%
Immunization Programs
35%
Conjugate Vaccines
34%
Pneumococcal Infections
32%
Seroepidemiologic Studies
31%
10-valent pneumococcal conjugate vaccine
29%
Immunity
28%
Pneumococcal Vaccines
28%
Child
27%
Serogroup
27%
Immunoglobulin G
23%
Vaccination
21%
Text Messaging
19%
Biomarkers
18%
Immunization
17%
Kenya
17%
Measles virus
14%
India
14%
Bangladesh
14%
Measles Vaccine
14%
Cell Phone
13%
Motivation
13%
Population
12%
Antibodies
12%
Tanzania
12%
Malaria
11%
Pakistan
11%
Confidence Intervals
11%
Systematic Reviews
11%
Vaccine-Preventable Diseases
10%
Vaccines
10%
Prospective Studies
10%
Randomized Controlled Trials
10%
Cohort Studies
10%
Serum
10%
Costs and Cost Analysis
9%
rubella antibodies
9%
Specimen Handling
8%
Caregivers
8%
Immunoenzyme Techniques
8%
Cost-Benefit Analysis
8%
13-valent pneumococcal vaccine
8%
Tetanus Antitoxin
8%
Rubella virus
8%
Fever
7%
Mass Vaccination
7%
Pneumococcal Meningitis
7%
Agriculture & Biology
measles
40%
Zambia
25%
vaccination
23%
immunity
15%
immunization
13%
serological surveys
12%
vaccines
11%
value added
10%
household surveys
9%
Grenada
8%
seroprevalence
7%
stakeholders
7%
antitoxins
7%
cohort studies
6%
young adults
6%
households
6%
marine mammals
6%
tetanus
6%
national surveys
6%
confidence interval
6%
cross-sectional studies
6%
pneumonia
6%
blood sampling
5%
Bangladesh
5%
conservation status
5%
cost effectiveness
5%
Social Sciences
vaccination
27%
coverage
19%
Zambia
11%
value added
10%
cross-sectional study
10%
SMS
6%
Bangladesh
5%
slum
5%
immunity
5%
costs
5%
infant
5%